Pectointercostal fascia blocks for Post-operative Pain

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Post-operative PainPectointercostal fascia blocks - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking to see if a regional block helps with pain relief for those who have undergone heart surgery.

Eligible Conditions
  • Post-operative Pain

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Every 6 hours for 24 hours post-operatively

12 hours
Opioid consumption
2 weeks
ICU length of stay
24 hours
Local anesthetic systemic toxicity effects
Time to extubation
24 hours post-operatively
Opioid consumption in 24 hours
4 weeks
Surgical site infection rate
Hour 24
Pain score

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Intervention
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

156 Total Participants · 2 Treatment Groups

Primary Treatment: Pectointercostal fascia blocks · Has Placebo Group · Phase 4

Intervention
Procedure
Experimental Group · 1 Intervention: Pectointercostal fascia blocks · Intervention Types: Procedure
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: every 6 hours for 24 hours post-operatively

Who is running the clinical trial?

University of AlbertaLead Sponsor
816 Previous Clinical Trials
376,668 Total Patients Enrolled
Wing LamPrincipal InvestigatorUniversity of Alberta

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are expected to be fast track candidates post-operatively.
You are scheduled for cardiac bypass grafting and/or single valve surgery requiring cardiopulmonary bypass.
References